⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IOVA News
Iovance Biotherapeutics, Inc. Common Stock
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
IOVA
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
globenewswire.com
IOVA
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
globenewswire.com
IOVA
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
prnewswire.com
IOVA
MRK
LLY
JNJ
Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
globenewswire.com
IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
IOVA
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
prnewswire.com
GTBP
GDTC
PSTV
IOVA
IMAB
GTBP
GDTC
PSTV
IOVA
IMAB
Advancing Cancer Research Brings New Hope for Patients Worldwide
prnewswire.com
IOVA
MRK
AZN
BMY